Title: Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism.
Journal: Chemical research in toxicology 20171120
Title: Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495).
Journal: ChemMedChem 20111104
Title: A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.
Journal: Cancer chemotherapy and pharmacology 20110801
Title: Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women.
Journal: Rapid communications in mass spectrometry : RCM 20110515
Title: Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.
Journal: BMC cancer 20110101
Title: Profiling oestrogens and testosterone in human urine by stable isotope dilution/benchtop gas chromatography-mass spectrometry.
Journal: Steroids 20101212
Title: Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.
Journal: Journal of cardiovascular pharmacology 20101201
Title: Simultaneous determination of eight estrogens and their metabolites in serum using liquid chromatography with electrochemical detection.
Journal: Talanta 20100415
Title: The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.
Journal: PloS one 20100101
Title: The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.
Journal: BMC medicine 20100101
Title: Comparison of estrogens and estrogen metabolites in human breast tissue and urine.
Journal: Reproductive biology and endocrinology : RB&E 20100101
Title: Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Journal: Journal of medicinal chemistry 20091210
Title: Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.
Journal: Bioorganic & medicinal chemistry letters 20091201
Title: Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.
Journal: Gynecologic oncology 20091001
Title: The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.
Journal: British journal of cancer 20081104
Title: Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
Journal: Journal of medicinal chemistry 20071227
Title: The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.
Journal: British journal of cancer 20071217
Title: Evaluation of electrospray ionization and atmospheric pressure chemical ionization for simultaneous detection of estrone and its metabolites using high-performance liquid chromatography/tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071201
Title: HPLC for stress-free screening of potential prostate cancer marker catechol estrogens in urine using a diamond-electrode electrochemical and a fluorescence detector.
Journal: Journal of separation science 20070901
Title: Effects of a catechol-O-methyltransferase inhibitor on catechol estrogen-induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells.
Journal: International journal of cancer 20070415
Title: Estrogen metabolism modulates bone density in men.
Journal: Calcified tissue international 20070401
Title: Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.
Journal: Investigational new drugs 20070201
Title: Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol.
Journal: The Journal of steroid biochemistry and molecular biology 20070201
Title: 2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts.
Journal: Journal of cellular biochemistry 20061001
Title: Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol.
Journal: Anti-cancer drugs 20060901
Title: Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry.
Journal: Analytical chemistry 20060301
Title: The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.
Journal: Cancer research 20060101
Title: The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria.
Journal: Hereditary cancer in clinical practice 20060101
Title: A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050915
Title: A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
Journal: Journal of medicinal chemistry 20050811
Title: Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
Journal: Cancer research 20050701
Title: Effects of dioxin on metabolism of estrogens in waste incinerator workers.
Journal: Archives of environmental & occupational health 20050101
Title: The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Journal: Bone 20040901
Title: Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates.
Journal: International journal of cancer 20040420
Title: Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents.
Journal: British journal of cancer 20040223
Title: Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
Journal: Breast cancer research : BCR 20040101
Title: Comparison of ex vivo inhibitory effect between 2-hydroxyestradiol and its 17-sulfate on rat hepatic microsomal lipid peroxidation.
Journal: Lipids 20030801
Title: The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells.
Journal: The Journal of steroid biochemistry and molecular biology 20030201
Title: Evaluation of an EIA method for measuring serum levels of the estrogen metabolite 2-hydroxyestrone in adults.
Journal: Steroids 20010101
Title: Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
Journal: International journal of cancer 20000401
Title: Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate.
Journal: Molecular and cellular endocrinology 20000225
Title: Lewis KM, et al. pKa values of estrone, 17 beta-estradiol and 2-methoxyestrone. Steroids. 1979 Nov;34(5):485-99.
